Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB

Journal of Experimental Medicine

Volumn 185, Issue 11, 1997, Pages 1897-1907

  Boothby, Mark R ^a,b   Mora, Ana L ^a,b   Scherer, David C ^a,b   Brockman, Jeffrey A ^a,b   Ballard, Dean W ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL LINEAGE; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; I-KAPPA B PROTEINS; IMMUNOBLOTTING; INTERLEUKIN-2; MICE; MICE, TRANSGENIC; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TRANSCRIPTION FACTOR RELA;

EID: 0030925372     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.11.1897     Document Type: Article

References (65)

1. Jamieson, C., P.C. McCaffrey, A. Rao, and R. Sen. 1991. Physiologic activation of T cells via the T cell receptor induces NF-kappa B. J. Immunol. 147:416-420.
2. Kang, S.-M., A.-C. Tran, M. Grilli, and M.J. Lenardo. 1992. NF-κB subunit regulation in non-transformed CD4+ T lymphocytes. Science (Wash. DC). 256:1452-1456.
3. Chen D., and E. Rothenberg. 1993. Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol. Cell. Biol. 13:228-238.
4. Sen, J., L. Venkataraman, Y. Shinkai, J.W. Pierce, F.W. Alt, S.J. Burakoff, R. Sen. 1995. Expression and induction of nuclear factor-κB-related proteins in thymocytes. J. Immunol. 154:3213-3221.
5. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
6. Finco T., and A.S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 3:263-272.
7. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of associaton and dissociation. Genes Dev. 9:2723-2735.
8. Moore, N.C., J. Girdlestone, G. Anderson, J.J.T. Owen, and E.J. Jenkinson. 1995. Stimulation of thymocytes before and after positive selection results in the induction of different NF-κB/Rel protein complexes. J. Immunol. 155:4653-4660.
9. Sha, W.C., H.C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:321-330.
10. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (Lond.). 376:167-170.
11. Baeuerle, P.A., and D. Baltimore. 1996. NF-κB: Ten years after. Cell. 87:13-20.
12. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multi-organ inflamamtion and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell. 80:331-340.
13. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Gate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (Lond.). 373:531-536.
14. Köntgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9: 1965-1977.
15. Ghosh, S. 1995. Transcriptional regulation in lymphocyte differentiation. The Immunologist. 3:168-169.
16. Tan, T.H., G.P. Huang, A. Sica, P. Ghosh, H.A. Young, D.L. Longo, and N.R. Rice. 1992. κB site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by c-Rel. Mol. Cell Biol. 12:4067-4075.
17. Garoufalis, E., I. Kwan, R. Lin, A. Mustafa, N. Pepin, A. Roulston, J. Lacoste, and J. Hiscott. 1994. Viral induction of the human beta interferon promoter: modulation of transcription by NF-κB/Rel proteins and interferon regulatory factors. J. Virol. 68;4707-4715.
18. Brockman, J.A., D.C. Scherer, T.A. McKinsey, S.M. Hall, X. Qi, W.Y. Lee, and D.W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
19. Lewis D.B., C.C. Yu, K.A. Forbush, J. Carpenter, T.A. Sato, A. Grossman, D.H. Liggitt, and R.M. Perlmutter. 1989. Interleukin 4 expressed in situ selectively alters thymocyte development. J. Exp. Med. 173:89-100.
20. Scherer, D.C., J.A. Brockman, H.H. Bendall, G.M. Zhang, D.W. Ballard, and E.M. Oltz. 1996. Corepression of RelA and c-Rel inhibits immunoglobulin kappa chain gene transcription and rearrangement in precursor B lymphocytes. Immunity. 5:563-574.
21. Greaves, D.R., F.D. Wilson, G. Lang, and D. Kioussis. 1989. Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell. 56:979-986.
22. Kruisbeck, A.M. 1992. Isolation and fractionation of mono-nuclear cell populations. Curr. Prot. Immunol. 3.1.1-3.1.5.
23. Casey, L.S., A.H. Lichtman, and M. Boothby. 1992. IL-4 induces IL-2 receptor p75 β chain gene gene expression, and IL-2 dependent proliferation in mouse T lymphocytes. J. Immunol. 148:3418-3426.
24. Ballard D.W., W.H. Walker, S. Doerre, P. Sista, J.A. Molitor, E.P. Dixon, N.J. Peffer, M. Hannink, and W.C. Greene. 1990. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell. 63:803-814.
25. Singh, H.R., R. Sen, D. Baltimore, and P.A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (Lond.). 319;154-157.
26. + T cell deletion. Immunity. 3:321-333.
27. Holmes K., and B.J. Fowlkes. 1992. Immunofluorescence and cell sorting: preparation of cells and reagents for flow cytometry. Curr. Prot. Immunol. 5.3.1-5.2.11.
28. Kelley, L.L., W.F. Green, G.G. Hicks, M.C. Bondurant, M.J. Koury, and H.E. Ruley. 1994. Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53. Mol. Cell. Biol. 14:4183-4192.
29. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature (Lond.). 377:348-351.
30. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene. 9:3289-3297.
31. Verweij, C.L., M. Geerts, and L.A. Aarden. 1991. Activation of interleukin 2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266:14179-14182.
32. Lai, J.-H., G. Horvath, J. Subleski, J. Bruder, P. Ghosh, and T.-H. Tan. 1995. RelA is a potent transcriptional activator of the CD28 response element within the interleukin-2 promoter. Mol. Cell. Biol. 15:4260-4271.
33. Cross, S.L., N.F. Halden, M.J. Lenardo, and W.J. Leonard. 1989. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. Science (Wash. DC). 244:466-469.
34. Nossal, G.J.V. 1994. Negative selection of lymphocytes. Cell 76:229-239.
35. Sytwu H.-K., R.S. Liblau, and H.O. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5:17-30.
36. Tucek-Szabo, C.L., S. Andjelic, E. Lacy, K.B. Elkon, and J. Nikolic-Zugic. 1996. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis: activation-induced death can occur without Fas receptor. J. Immunol. 156:192-200.
37. Zheng, L., S.A. Boehme, J.M. Critchfield, J.C. Zuniga-Pflucker, M. Freedman, and M.J. Lenardo. 1994. Immunological tolerance by antigen-induced apoptosis of mature T lymphocytes. Adv Exp. Med. Biol. 365:81-89.
38. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science (Wash. DC). 274:787-789.
39. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Wash. DC). 274:782-784.
40. Abbadie, C., N. Kabrun, F. Bouali, J. Smardova, D. Stehelin, B. Banderbunder, and P.J Enrietto. 1993. High levels of c-Rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell. 75:899-912.
41. Jung, M., Y. Zhang, S. Lee, and A. Dritschlo. 1995. Correction of the radiation senstivity in ataxia-telangiectasia by a truncated IκBα. Science (Wash. DC). 268:1619-1621.
42. Grilli, M., M. Pizzi, M. Memo, and P.P. Spano. 1996. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science (Wash. DC). 264:1383-1386.
43. Huesman, M., B. Scott, P. Kisielow, and H. Von Boehmer. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell. 66:533-540.
44. Matsuyama T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T.M. Kundig, R. Amakawa, K. Kishihara, A. Wakeham et al. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:83-97.
45. + T cells in IRF-1 -/-mice. Immunity. 5:365-376.
46. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93-126.
47. Sprent, J. 1989. T lymphocytes and the thymus. In Fundamental Immunology. W.E. Paul, editor. Raven Press, NY. 69-93.
48. Crabtree, G.R. 1989. Contingent genetic regulatory events in T lympyhocyte activation. Science (Wash. DC). 243:355-361.
49. Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (Lond.). 352:621-624.
50. Willerford, D.M., J. Chen, J.A. Ferry, L. Davidson, A. Ma, and F.W. Alt. 1995. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3:521-530.
51. Doerre, S., P. Sista, S.C. Sun, D.W. Ballard, and W.C. Greene. 1993. The c-rel proto-oncogene product represses NF-κB p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 90:1023-1027.
52. Brach M.A., H.J. Gruss, D. Riedel, R. Mertelsmann, and F. Herrmann. 1992. Activation of NF-kappa B by interleukin 2 in human blood monocytes. Cell Growth Diff. 3:421-427.
53. Arima, N., W.A. Kuziel, T.A. Grdina, and W.C. Greene. 1992. IL-2-induced signal transduction involves the activation of nuclear NF-kappa B expression. J. Immunol. 149:83-91.
54. Van Parijs, L., A. Ibraghimov, and A.K. Abbas. 1996. The role of costimulation and Fas in T cell apoptosis and tolerance. Immunity. 4:321-328.
55. Veis, D.J., C.M. Sorenson, J.R. Shutter, and S.J. Korsmeyer. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:229-240.
56. Ma, A., J.C. Pena, B. Chang, E. Margosian, L. Davidson, F.W. Alt, and C.B. Thompson. 1995. Bcl-x regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA. 92:4763-4767.
57. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K.-I. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, and D.Y. Loh. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science (Wash. DC). 267:1506-1510.
58. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
59. Boise, L.H., and C.B. Thompson. 1996. Hierarchical control of lymphocyte survival. Science (Wash. DC). 274:67-68.
60. + thymic selection in humans lacking ZAP-70 kinase. Cell. 76:947-958.
61. Elder, M.E., D. Lin, J. Clever, A.C. Chan, T.J. Hope, A. Weiss, and T.G. Parslow. 1994. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science (Wash. DC). 264:1596-1599.
62. Chan, A.C., T.A. Kadlecek, M.E. Elder, A.H. Filipovich, W.L. Kuo, M. Iwashima, T.G. Parslow, and A. Weiss. 1994. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science (Wash. DC). 264:1599-1601.
63. Park, S.Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, H. Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T. Saito. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity. 3:771-782.
64. Fischer, M., I. McNeil, T. Suda, J.E. Cupp, K. Shortman, and A. Zlotnik. 1991. Cytokine production by mature and immature thymocytes. J. Immunol. 146:3452-3456.
65. Rincon, M., and R.A. Flavell. 1996. Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells. Mol. Cell. Biol. 16:1074-1084.